21688 results for «»
21688 results
Complications of valve-in-valve TAVI
18 Nov 2025 – From PCR London Valves 2025
This session addresses the complex complications associated with valve-in-valve TAVI procedures. Topics include delayed coronary compromise, unexpected clinical scenarios, the importance of recognizing surgical bioprosthesis types, the dual role of calcium in TAVI, and intricate left ventricular complications that can arise post valve-in-valve interventions.
Transcatheter tricuspid valve replacement: pioneering techniques and solutions for high-risk patients
18 Nov 2025 – From PCR London Valves 2025
This session explores advanced transcatheter tricuspid valve replacement techniques and outcomes. It features cases of TricValve dysfunction due to intrinsic regurgitation, pioneering 'chimney technique' implantation in complex patients, right heart remodeling post-intervention, and innovative solutions including percutaneous heterotopic bicaval valve implantation following pericardiectomy.
TAV in TAVI with coronary protection - LIVE Case
18 Nov 2025 – From PCR London Valves 2025
Watch a LIVE case followed by a recorded case, regarding a 78-year-old female, with a previous TAVI in 2014 (Sapien 3 26) and sarcoidosis, who presented with symptomatic TAVI stenosis. There was a mis-commissural alignment, with the neoskirt plane above the coronary plane. Under general anesthesia,...
TAVI in challenging anatomies
18 Nov 2025 – From PCR London Valves 2025
This session focuses on the challenges of performing TAVI in complex anatomical settings. It covers issues such as valve compression, hypertrophic cardiomyopathy-related left ventricular responses, alternative management strategies during crises, and handling anatomical complexities like membranous septal aneurysm at the annulus and sinus of Valsalva in...
Paravalvular leak closure - Part 4
18 Nov 2025 – From PCR London Valves 2025
This session delves into the complexities of paravalvular leak closure with a focus on challenging scenarios including unusual TAVI complications in the mitral position, management of mega paravalvular leaks using jumbo devices, and strategies when closure itself poses an obstacle. It also covers acute peri-operative aortic...
Transcatheter solutions for failed mitral TEER
18 Nov 2025 – From PCR London Valves 2025
This session presents innovative transcatheter solutions for managing failed mitral TEER procedures. It highlights advanced closure strategies for inter-clip mitral regurgitation, percutaneous approaches for recurrent mitral regurgitation, novel chordae tendineae replacement techniques, and potential bailout strategies including atrial flow regulation implantation for recurrent heart failure.
PCR London Valves 2025: Best of Social Media Coverage
20 Nov 2025
This year’s coverage was built on innovative formats to support one clear strategy: sharing strong messages and high-quality education through well-prepared, creative content. The #PCRLV social media team was led by Pamela Gatto, and divided into 6 tracks: aortic, mitral, tricuspid, closure, imaging and nursing.
1-year SELUTION DeNovo results: drug-eluting balloon strategy vs. systematic drug-eluting stent in de novo coronary disease
29 Oct 2025
Guillaume Bonnet interviews Christian Spaulding about the SELUTION DeNovo Trial he presented at TCT 2025, in San Francisco.
Prof. Christian Spaulding, principal investigator of the study, discusses the trial design, key outcomes, breaks down the nuances behind the sirolimus DCB strategy versus contemporary DES, and shares insights...
Author
Author
TAVI complications - Part 3
18 Nov 2025 – From PCR London Valves 2025
This session provides a detailed examination of TAVI-related complications and their management. Key topics include the STJ-sling technique, valve frame underexpansion diagnosis, real-time intracardiac echocardiography utility, recurrent cardiac arrest scenarios during TAVI, and management strategies for valve in-folding in self-expanding transcatheter valves.
SMT’s Hydra TAVR Valve demonstrates sustained safety, durability, and hemodynamic performance at 5 Years
19 Nov 2025
Unusual structural interventions - Part 2
18 Nov 2025 – From PCR London Valves 2025
This session highlights unusual structural interventions in cardiology, featuring comprehensive CT screening for left atrial appendage closure, management of procedural complications, novel access techniques for balloon aortic valvuloplasty, transcatheter treatment of mitral bioprosthetic valve vegetation, and percutaneous ventricular septal rupture closure success criteria.
Featured research - TAVI - Part 12
18 Nov 2025 – From PCR London Valves 2025
This session presents advanced research on transcatheter aortic valve implantation (TAVI), featuring an extensive 30-year in-vitro durability analysis of the Evolut self-expanding valve. It also covers predictive studies on valve-in-valve procedure volumes comparing Japan and the United States, insights into TAVI in patients with left ventricular...
Featured research - TAVI - Part 13
18 Nov 2025 – From PCR London Valves 2025
This session delves into key clinical and procedural advances in TAVI, including the randomized PAF-TAVI trial assessing amiodarone for preventing post-TAVI atrial fibrillation, cost comparisons of balloon-expandable tissue preservation valves versus other devices, leaflet modification methods to reduce coronary obstruction risk, optimization techniques for valve-in-valve TAVI...
Reflecting on the year 2025 in interventional cardiology: what was new and what is coming?
27 Nov 2025
Explore the latest and future trends in interventional cardiology with D. Milasinovic and S. Brugaletta!
Curious TAVI scenarios - Part 3
18 Nov 2025 – From PCR London Valves 2025
This session examines unusual and challenging clinical scenarios following TAVI, including presentations of cyanosis, evolving valvular defects such as growing paravalvular holes, atypical imaging findings, paradoxical transvalvular gradients switching from aortic regurgitation to stenosis resolved by postdilatation, and bicoronary protection techniques in patients with low coronary...
EuroPCR 2026: Promotional kit
When a surgical valve needs a second life
27 Feb 2026
A 79-year-old patient previously treated with surgical aortic valve replacement was referred after an episode of acute cardiac decompensation. Although clinically stabilised, further evaluation revealed degeneration of the bioprosthesis, and mixed aortic valve pathology.
This case focuses on the diagnostic assessment and the strategic considerations guiding the...
Author
How are the 2025 ESC EACTS valvular guidelines going to impact my TAVI programme?
17 Dec 2025 – From PCR London Valves 2025
Bernard Prendergast and Fabien Praz discuss updates from the new ESC/EACTS guidelines on aortic stenosis. Key changes include expanding TAVI to patients aged 70 and older, supporting early intervention in asymptomatic patients, and providing guidance for bicuspid aortic valves. These updates emphasise shared decision-making, careful patient...
The importance of PPM in younger patients in TAVI valve choice
08 Dec 2025
Kristoffer Russell discusses prosthesis–patient mismatch (PPM), which can increase mortality, heart failure hospitalisations, and reduce functional recovery, especially in younger patients. While less common after TAVI than surgical valve replacement, studies show up to 30% of younger, low-risk TAVI patients still experience moderate or severe PPM,...
Wiam Elshami
Sharjah, United Arab Emirates
